Results 291 to 300 of about 155,806 (387)

Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies

Nature Medicine, 2013
A. Lee, Chad Tang, M. Rao, I. Weissman, Joseph C. Wu   +4 more
semanticscholar   +1 more source

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

BMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan, Qiujie Fang, Cao Fei, Ziyuan Wang, Zhaowei Chen, Guojun Chen, Zhiming Xu, Shu Xu, Zhitong Chen   +8 more
wiley   +1 more source

PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3. [PDF]

Cell Death Dis
Tokumura K, Fukasawa K, Ichikawa J, Sadamori K, Hiraiwa M, Hinoi E.   +5 more
europepmc   +1 more source

K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling

Cell, 2015
Man-Tzu Wang, M. Holderfield, Jacqueline Galeas, R. Delrosario, M. To, A. Balmain, F. McCormick   +6 more
semanticscholar   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Value of hs-cTnT, sST2, and Lp-PLA2 in the classification of acute coronary syndrome. [PDF]

Exp Ther Med
Peng H, Lubanga N, Sun C, He B, Mei YP, Wang Y.   +5 more
europepmc   +1 more source

The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas

Cancer immunology research, 2015
Y. Komohara, Tomoko Morita, D. A. Annan, Hasita Horlad, Koji Ohnishi, S. Yamada, T. Nakayama, S. Kitada, S. Suzu, I. Kinoshita, H. Dosaka-akita, K. Akashi, M. Takeya, M. Jinushi   +13 more
semanticscholar   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

Safety assessment of rat embryonic fraction for in vivo regenerative therapy

Biology Open
Sivarama Prasad Darsi, Somorita Baishya, Veerababu Nagati, Kala Kumar Bharani, Satyanarayana Swamy Cheekatla, Sujesh Kumar Darsi, Adi Reddy Kamireddy, Ram Reddy Barra, Ashok Kumar Devarasetti, Sreedhar Surampudi, Jayaram Reddy Singireddy, Siva Kumar Kandula, Anil Kumar Pasupulati   +12 more
doaj   +1 more source

OT17 a novel microsatellite stable colorectal cancer cell line and organoid model for investigating <i>BRAF V600E</i> mutant tumorigenesis and targeted therapeutics. [PDF]

Biochem Biophys Rep
Zheng C, Tang X, Wang S, Xu Y, Jia K, Gao G, Wei G, Niu G, Wu Y, Qian X, Zhu Y, Xiang D.   +11 more
europepmc   +1 more source